Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Portola Pharmaceuticals Inc. PTLA

Healthcare Biotechnology
"Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of... see more

Recent & Breaking News (NDAQ:PTLA)

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

PR Newswire March 14, 2020

PORTOLA 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Portola Pharmaceuticals, Inc. - PTLA

Business Wire March 13, 2020

PTLA Final Deadline Monday: Rosen, a Globally Recognized Firm, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action - PTLA

Business Wire March 13, 2020

SHAREHOLDER ALERT: PTLA WBK HPQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 13, 2020

PTLA FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020

ACCESSWIRE IA March 13, 2020

PTLA INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020

GlobeNewswire March 12, 2020

ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action - PTLA

GlobeNewswire March 12, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, QD and AAN

ACCESSWIRE IA March 12, 2020

SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ALGN, OPRA, PTLA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

GlobeNewswire March 11, 2020

SHAREHOLDER ALERT: PTLA LK JELD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 11, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA

ACCESSWIRE IA March 11, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, WBK and WWE

ACCESSWIRE IA March 11, 2020

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Business Wire March 11, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PTLA, WWE and TLRY

ACCESSWIRE IA March 11, 2020

PTLA UPCOMING DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Portola Pharmaceuticals Inc. Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 16, 2020

ACCESSWIRE IA March 11, 2020

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ALGN, PTLA, QD and WWE

GlobeNewswire March 10, 2020

CLASS ACTION UPDATE for PTLA, WWE and JELD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA March 10, 2020

ROSEN, INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16 Deadline in Securities Class Action - PTLA

ACCESSWIRE IA March 10, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, WWE and CAN

ACCESSWIRE IA March 10, 2020

SHAREHOLDER ALERT: CLAIMSFILER REMINDS PTLA, QD, TUP, TVTY INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

GlobeNewswire March 9, 2020